Robinhood gives you the tools you need to put your money in motion. You can buy or sell CARA and other ETFs, options, and stocks.
CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs). Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain.
52 Week high
52 Week low
— per share
Expected Aug 8, After Hours